Literature DB >> 16303032

Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.

R H Hunt1.   

Abstract

Proton-pump inhibitors have been highly effective in managing acid-related gastrointestinal disorders, but challenges remain. This paper reviews the challenges in the management of patients with gastro-oesophageal symptoms who do not respond adequately to proton-pump inhibitor therapy; the treatment of patients with non-variceal upper gastrointestinal bleeding; the prevention of stress-related mucosal bleeding; the treatment and prevention of non-steroidal anti-inflammatory drug-related gastrointestinal injury; and the optimal combination of antisecretory and antibiotic therapy for the eradication of Helicobacter pylori infection, all of which represent unmet clinical needs. Antisecretory therapy with a rapid onset of action and sustained antisecretory effect may help to address some of the unmet needs discussed, especially in the management of gastro-oesophageal reflux disease, non-variceal upper gastrointestinal bleeding and non-steroidal anti-inflammatory drug-related gastrointestinal complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303032     DOI: 10.1111/j.1365-2036.2005.02715.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.

Authors:  R H Hunt; D Armstrong; M Yaghoobi; C James; Y Chen; J Leonard; J M Shin; E Lee; D Tang-Liu; G Sachs
Journal:  Aliment Pharmacol Ther       Date:  2008-04-25       Impact factor: 8.171

Review 2.  Potent Acid Suppression with PPIs and P-CABs: What's New?

Authors:  Richard H Hunt; Carmelo Scarpignato
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

3.  Novel approaches to inhibition of gastric acid secretion.

Authors:  George Sachs; Jai Moo Shin; Richard Hunt
Journal:  Curr Gastroenterol Rep       Date:  2010-12

4.  Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

Authors:  Richard H Hunt; Carmelo Scarpignato
Journal:  Clin Transl Gastroenterol       Date:  2015-10-29       Impact factor: 4.488

5.  The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis.

Authors:  Jiamin Gao; Senlin Ma; Siyuan Xu; Mingquan Chen
Journal:  Dis Markers       Date:  2022-06-28       Impact factor: 3.464

Review 6.  Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region.

Authors:  Khean Lee Goh; Myung Gyu Choi; Ping I Hsu; Hoon Jai Chun; Varocha Mahachai; Udom Kachintorn; Somchai Leelakusolvong; Nayoung Kim; Abdul Aziz Rani; Benjamin C Y Wong; Justin Wu; Cheng Tang Chiu; Vikram Shetty; Joseph C Bocobo; Melchor M Chan; Jaw-Town Lin
Journal:  J Neurogastroenterol Motil       Date:  2016-07-30       Impact factor: 4.924

Review 7.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

Review 8.  The Physiology of the Gastric Parietal Cell.

Authors:  Amy C Engevik; Izumi Kaji; James R Goldenring
Journal:  Physiol Rev       Date:  2019-10-31       Impact factor: 37.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.